FI962341A - Uudet substituoidut oksatsolidiinit - Google Patents

Uudet substituoidut oksatsolidiinit Download PDF

Info

Publication number
FI962341A
FI962341A FI962341A FI962341A FI962341A FI 962341 A FI962341 A FI 962341A FI 962341 A FI962341 A FI 962341A FI 962341 A FI962341 A FI 962341A FI 962341 A FI962341 A FI 962341A
Authority
FI
Finland
Prior art keywords
pct
date jun
sec
compounds
substituted oxazolidines
Prior art date
Application number
FI962341A
Other languages
English (en)
Swedish (sv)
Other versions
FI119987B (fi
FI962341A0 (fi
Inventor
Alfred Sallmann
Hans-Peter Gschwind
Eric Francotte
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI962341A0 publication Critical patent/FI962341A0/fi
Publication of FI962341A publication Critical patent/FI962341A/fi
Application granted granted Critical
Publication of FI119987B publication Critical patent/FI119987B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI962341A 1993-12-10 1996-06-05 Menetelmä uusien substituoitujen oksatsolidiinien valmistamiseksi FI119987B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH369193 1993-12-10
CH369193 1993-12-10
PCT/EP1994/003937 WO1995015953A1 (en) 1993-12-10 1994-11-28 Novel substituted oxazolidines
EP9403937 1994-11-28

Publications (3)

Publication Number Publication Date
FI962341A0 FI962341A0 (fi) 1996-06-05
FI962341A true FI962341A (fi) 1996-06-05
FI119987B FI119987B (fi) 2009-05-29

Family

ID=4261454

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962341A FI119987B (fi) 1993-12-10 1996-06-05 Menetelmä uusien substituoitujen oksatsolidiinien valmistamiseksi

Country Status (14)

Country Link
US (1) US5635524A (fi)
EP (1) EP0733047B1 (fi)
JP (1) JP3792713B2 (fi)
KR (1) KR100354528B1 (fi)
AT (1) ATE171169T1 (fi)
AU (1) AU692809B2 (fi)
CA (1) CA2177171C (fi)
DE (1) DE69413417T2 (fi)
ES (1) ES2121621T3 (fi)
FI (1) FI119987B (fi)
HU (1) HU221500B (fi)
NO (1) NO306463B1 (fi)
NZ (1) NZ276421A (fi)
WO (1) WO1995015953A1 (fi)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4064257A (en) * 1976-07-19 1977-12-20 Syntex (U.S.A.) Inc. Thiazole cardiovascular agents
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
IE903614A1 (en) * 1989-10-10 1991-04-24 Glaxo Group Ltd Phenethanolamine Compound

Also Published As

Publication number Publication date
FI119987B (fi) 2009-05-29
DE69413417D1 (de) 1998-10-22
HU9601585D0 (en) 1996-08-28
HUT74689A (en) 1997-01-28
JP3792713B2 (ja) 2006-07-05
FI962341A0 (fi) 1996-06-05
ES2121621T3 (es) 1998-12-01
NO306463B1 (no) 1999-11-08
NZ276421A (en) 1998-01-26
ATE171169T1 (de) 1998-10-15
EP0733047B1 (en) 1998-09-16
CA2177171C (en) 2006-01-17
KR100354528B1 (ko) 2002-12-18
NO962424L (no) 1996-06-07
WO1995015953A1 (en) 1995-06-15
CA2177171A1 (en) 1995-06-15
DE69413417T2 (de) 1999-03-04
US5635524A (en) 1997-06-03
EP0733047A1 (en) 1996-09-25
AU1068395A (en) 1995-06-27
AU692809B2 (en) 1998-06-18
JPH09506357A (ja) 1997-06-24
NO962424D0 (no) 1996-06-07
HU221500B (en) 2002-10-28

Similar Documents

Publication Publication Date Title
KR970704435A (ko) 헤테로시클릭 화합물의 도파민-D 리간드로서의 용도(Use of Heterocyclic Compounds as Dopamines-D Ligands)
NO306345B1 (no) Piperidin-derivater med PAF antagonist-aktivitet, anvendelse derav og farmasöytisk blanding
ES2135769T3 (es) Derivados de isotiourea como inhibidores de no-sintasa.
HU9602695D0 (en) Pyrimidine or triazine carboxylic acid derivatives to be used as medicaments
BR9507677A (pt) Composto composição farmacéutica processo para a profilaxia ou para o tratamento de condições associadas à inflamação à artrite ou à dor em um mamifero uso do composto processo para a preparação do composto e novo intermediário
FR2549049B1 (fr) Nouvelles amidines, leur procede de preparation et leur application therapeutique
DK0728138T3 (da) Anthracyclinderivater
DE69512208D1 (de) Aminosäurederivate und ihre verwendung als phospholipase-a2-inhibitoren
FI962341A (fi) Uudet substituoidut oksatsolidiinit
ES2121218T3 (es) Fenoxifenilciclopentenilhidroxiureas.
SE9202218D0 (sv) Pharmacologically active alfa-(tertiary-aminomethyl)-benzenemethanol derivatives, pharmaceutical composition containing them, therapeutical use thereof and processes for their preparation
CA2105215A1 (en) Novel oxazolidines
KR890014115A (ko) 4-(3-포스포노-2-프로페닐)-2-피페라진카르복실산의 신규한 용도

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG

FG Patent granted

Ref document number: 119987

Country of ref document: FI

MA Patent expired